Call (289) 812-0046
Clinical Trial
For adults (≥ 18 yo) with chronic spontaneous urticaria (subcutaneous study drug)
CLINICAL TRIAL
Phase 3b | Oral tablet | 52 week treatment period
Trial ID: NCT06042478
RECRUITING
Exclusion Criteria: